Parkinson’s disease

Showing 6 posts of 21 posts found.

UCB launches ‘Parkinson’s Well-Being Map’

April 13, 2012
Medical Communications Parkinson's disease, UCB

UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …

GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011
Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

GSK Parkinson’s drug impresses at phase III

March 21, 2011
Research and Development ADVANCE-PD, GSK, GlaxoSmithKline, IPX066, Impax Pharmaceuticals, Parkinson's disease, Parkinson’s disease

GlaxoSmithKline’s advanced Parkinson’s disease drug IPX066 has impressed in a head to head trial against it nearest rival. The phase …

Merck Serono and Domain to co-develop Parkinson’s drugs

January 18, 2011
Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4

Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010
Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …

The Gateway to Local Adoption Series

Latest content